• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 417644 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414160603 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414160603 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Traders Get Bullish on Shares of Pacific Biosciences of California , Shares Up 8.3% (PACB)

Published on Tue, 01/08/2013 - 13:22
By Peter Chu

Pacific Biosciences of California (NASDAQ:PACB) is one of today's best performing low-priced stocks, up 8.3% to $1.95 on 1.3x average daily volume. Thus far today, Pacific Biosciences of California has traded 432,000 shares, vs. average volume of 332,000 shares per day. The stock has outperformed the Dow (8.3% to the Dow's -0.6%) and outperformed the S&P 500 (8.3% to the S&P's -0.6%) during today's trading.

Pacific Biosciences of California (NASDAQ:PACB) has potential upside of 8.5% based on a current price of $1.95 and analysts' consensus price target of $2.12. The stock should hit resistance at its 200-day moving average (MA) of $2.03, as well as support at its 50-day MA of $1.49.

In the past 52 weeks, shares of Pacific Biosciences of California have traded between a low of $1.06 and a high of $5.27 and are now at $1.95, which is 84% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 1.3% while the 50-day MA has advanced 2.5%.

Pacific Biosciences of California Inc. has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. The Company's system enables real-time analysis of biomolecules with single molecule resolution.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Computer Sciences (CSC) Approaches New U...

Shares of Computer Sciences (NYSE:CSC) opened today above their pivot of $59.16 and hav ...

Watch for Shares of Compuware (CPWR) to ...

Shares of Compuware (NASDAQ:CPWR) have bullishly opened above the pivot of $9.97 today ...

Range Resources (RRC) Breaks Through Sup...

Shares of Range Resources (NYSE:RRC) opened today below their pivot of $68.66 and have ...

Nicor (GAS) Breaks Through Support at $5...

Nicor (NYSE:GAS) has opened bearishly below the pivot of $54.41 today and has reached t ...

Eastman Chemical (EMN) Crosses Pivot Poi...

Shares of Eastman Chemical (NYSE:EMN) opened today below their pivot of $78.05 and have ...

Next Resistance Level for PG&E (PCG) is ...

PG&E (NYSE:PCG) has opened bullishly above the pivot of $46.28 today and has reached th ...

Coca-Cola Enterprises (CCE) Breaks Throu...

Shares of Coca-Cola Enterprises (NYSE:CCE) have bearishly opened below the pivot of $42 ...

Watch for Shares of Ventas (VTR) to Appr...

Shares of Ventas (NYSE:VTR) opened today below their pivot of $67.63 and have already r ...